Overview

Phase II Study of the Effects of rhPDGF-BB Injection on Lateral Epicondylitis

Status:
Completed
Trial end date:
2014-10-21
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether recombinant human platelet-derived growth factor (rhPDGF-BB) Injection is effective in the treatment of lateral epicondylitis (tennis elbow).
Phase:
Phase 2
Details
Lead Sponsor:
BioMimetic Therapeutics
Treatments:
Becaplermin
Platelet-derived growth factor BB